Identify the optimal treatment approach for patients with gastrointestinal cancers based on current approvals, data, and guidelines
|
|
|
|
|
|
Incorporate biomarker testing and targeted treatment to provide optimal, individualized patient care
|
|
|
|
|
|
Evaluate the efficacy and safety of biomarker-targeted therapies in late-stage clinical trials
|
|
|
|
|
|